European Companies Search Engine

EU funding (€1,498,456): Molecular Mechanisms of Persistent Antigenic Stimulation in Cytomegalovirus Infection Fts1 Apr 2011 Financial Transparency System

Overview

Text

Project

Subject of Grant or Contract Molecular mechanisms of persistent antigenic stimulation in cytomegalovirus infection
Responsible Department ERC - European Research Council Executive Agency
Programme Name 1.1.1 - Seventh Research framework programme (including sixth Research framework programme)
Type of Contract* Action Grant
Reference of the Legal Commitment (LC) EMI.5556
Management Type Direct management
Geographical Zone -
Budget BGUE
Action Location -
Commitment Total Amount (EUR) (A+B) 1,498,456.00
Project end Date 30/09/2016
Commitment Contracted Amount (EUR) (A) 1,498,456.00
Budget Line Name Ideas
Funding Type Grant
Additional/Reduced Amount (EUR) (B) 0.00
Year 2011
Reference (Budget) CPM.260934-582001.1
Commitment Consumed Amount (EUR) 1,498,456.00
Budget Line Number 08 10 01
Project Start Date 01/04/2011
Expense Type Operational

Beneficiaries

Coordinator Yes
Address ??????????????? ?
Beneficiary’s Contracted Amount (EUR) 1,498,456.00
Beneficiary’s Estimated Contracted Amount (EUR) 1,498,456.00
Postal Code 38124
Beneficiary Country Germany
Beneficiary’s Estimated Consumed Amount (EUR) 1,498,456.00
VAT Number of Beneficiary DE114815244
Beneficiary Group Code LE05
Not-for-Profit Organisation (Nfpo) Yes
Beneficiary Type Private Companies
Name of Beneficiary HELMHOLTZ ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH*
Nuts2 Braunschweig
City BRAUNSCHWEIG
Non-Governmental Organisation (NGO) No

The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Helmholtz-Zentrum für Infektionsforschung GmbH, Braunschweig, Germany.

Creative Commons License The visualizations for "HELMHOLTZ ZENTRUM für INFEKTIONSFORSCHUNG GmbH - EU funding (€1,498,456): Molecular Mechanisms of Persistent Antigenic Stimulation in Cytomegalovirus Infection" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.